| Carol D Morris, MD | |
|
601 N Caroline St, Baltimore, MD 21287-0006 | |
| (443) 287-2121 | |
| Not Available |
| Full Name | Carol D Morris |
|---|---|
| Gender | Female |
| Speciality | Orthopedic Surgery |
| Experience | 30 Years |
| Location | 601 N Caroline St, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336124312 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 215300 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mskcc Surgery Group | 0345131405 | 278 |
News Archive
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Forensic DNA profiling has become a standard tool in the search for missing people in the aftermath of mass violence and disaster, but until now there has been very little effort to identify and analyze the major ethical and policy challenges associated with this new use of genetic technology.
By pulling out of the running to be the next secretary of Veterans Affairs, Cleveland Clinic head Toby Cosgrove has given the administration a chance to think harder about what the VA needs most right now.
The December issue of The American Journal of Gastroenterology is now available and features new clinical research across a wide range of gastroenterology and hepatology topics, including health disparities, colorectal cancer, cirrhosis, pediatric gastroenterology, the environmental impact of endoscopy, and more.
› Verified 6 days ago
| Entity Name | Mskcc Surgery Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699766261 PECOS PAC ID: 0345131405 Enrollment ID: O20040320000446 |
News Archive
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Forensic DNA profiling has become a standard tool in the search for missing people in the aftermath of mass violence and disaster, but until now there has been very little effort to identify and analyze the major ethical and policy challenges associated with this new use of genetic technology.
By pulling out of the running to be the next secretary of Veterans Affairs, Cleveland Clinic head Toby Cosgrove has given the administration a chance to think harder about what the VA needs most right now.
The December issue of The American Journal of Gastroenterology is now available and features new clinical research across a wide range of gastroenterology and hepatology topics, including health disparities, colorectal cancer, cirrhosis, pediatric gastroenterology, the environmental impact of endoscopy, and more.
› Verified 6 days ago
| Entity Name | Msk Nassau |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053875229 PECOS PAC ID: 8628311685 Enrollment ID: O20190522000541 |
News Archive
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Forensic DNA profiling has become a standard tool in the search for missing people in the aftermath of mass violence and disaster, but until now there has been very little effort to identify and analyze the major ethical and policy challenges associated with this new use of genetic technology.
By pulling out of the running to be the next secretary of Veterans Affairs, Cleveland Clinic head Toby Cosgrove has given the administration a chance to think harder about what the VA needs most right now.
The December issue of The American Journal of Gastroenterology is now available and features new clinical research across a wide range of gastroenterology and hepatology topics, including health disparities, colorectal cancer, cirrhosis, pediatric gastroenterology, the environmental impact of endoscopy, and more.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carol D Morris, MD 633 3rd Ave, Box 3, New York, NY 10017-6706 Ph: () - | Carol D Morris, MD 601 N Caroline St, Baltimore, MD 21287-0006 Ph: (443) 287-2121 |
News Archive
Regeneron Pharmaceuticals has received marketing approval for their eye drug - Eylea, an injection meant to treat a common cause of blindness in older people. Eylea can be used to treat "wet" age-related macular degeneration. The only other drug approved for the condition is Lucentis from Roche, which was approved in 2006.
Forensic DNA profiling has become a standard tool in the search for missing people in the aftermath of mass violence and disaster, but until now there has been very little effort to identify and analyze the major ethical and policy challenges associated with this new use of genetic technology.
By pulling out of the running to be the next secretary of Veterans Affairs, Cleveland Clinic head Toby Cosgrove has given the administration a chance to think harder about what the VA needs most right now.
The December issue of The American Journal of Gastroenterology is now available and features new clinical research across a wide range of gastroenterology and hepatology topics, including health disparities, colorectal cancer, cirrhosis, pediatric gastroenterology, the environmental impact of endoscopy, and more.
› Verified 6 days ago
Robert J Brumback, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3333 North Calvert Street, Suite 400, Baltimore, MD 21218 Phone: 410-554-2270 Fax: 410-261-2726 | |
Dr. Milford Howarth Marchant Jr., M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2900 S Hanover St, Baltimore, MD 21225 Phone: 410-350-8336 Fax: 410-350-7178 | |
Dr. Michelle Ghert, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 110 S Paca St Fl 6, Baltimore, MD 21201 Phone: 614-397-2721 | |
Henry R Boucher, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3333 North Calvert Street, Suite 400, Baltimore, MD 21218 Phone: 410-554-2270 Fax: 410-261-2726 | |
John J Carbone, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3001 S Hanover St, Gruehn Bldg, Ste 502, Baltimore, MD 21225 Phone: 410-350-8300 | |
Dr. Dawn Laporte, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 N Caroline St, Rm 5210, Baltimore, MD 21287 Phone: 410-955-3134 | |
Paul C Mcafee, M.D., MBA Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3333 N Calvert St Ste 655, Baltimore, MD 21218 Phone: 410-554-2175 Fax: 410-554-2917 |